These findings indicate that THBS1/CD47 signaling is a critical bridge mediating the interaction between M1 macrophages and NETs‐associated neutrophils, and identify 4‐OI as a promising therapeutic candidate for the treatment of myocardial IR injury following HT. Here, CD47 is linked to hematocrit.